# Boquan Capital

> Boquan Capital is a VC fund in Hongkou backing Biotechnology and Pharmaceutical. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Hongkou, China
- Total investments: 5
- Last investment: Dec 2025
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.boquancapital.com/

Boquan Capital is a venture capital firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 40% |
| Pharmaceutical | 2 | 40% |
| Medical | 1 | 20% |
| Robotics | 1 | 20% |
| Software | 1 | 20% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 60% |
| Series B | 1 | 20% |
| Series C | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 4 | 80% |
| United States | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Chunfeng Huayu | Chunfeng Huayu is a medical robot developer, primarily engaged in the research and development of orthopedic and neurosurgical robots, medical device manufacturing |  | Series B | Dec 01, 2025 |  |
| DIGITWIN Technologies | DIGITWIN Technologies develops products and solutions in the field of 3D digital twins and enterprise metaverses, including spatial computing technologies to interact with the physical and digital worlds. |  | Series A | Dec 18, 2023 |  |
| ENSEM Therapeutics | ENSEM Therapeutics is a pioneering drug discovery and development company that leverages its unique Kinetic EnsembleTM platform to develop innovative small-molecule precision medicines for oncology, with potential expansion into genetic disorders and other disease areas. | $10M | Series A | Oct 23, 2023 |  |
| Taichu Biotechnology | Taichu Biotechnology offers customized CRO+CDMO technical services for single and combined business sectors for the development and manufacturing of various novel pharmaceuticals. |  | Series A | May 08, 2023 |  |
| Ark Biosciences | Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development of innovative therapeutics to address unmet medical need, especially in the area of respiratory viral infection and viral hepatitis, for global and China market. We strive to build a science-driven biopharmaceutical company that aims to be a leader inantiviral drug discovery and development. To achieve so, we aspire for the excellence of science and be innovative. We operate with a razor-sharp focus and aggressiveness with a timely and cost efficient manner. We create a healthy and rewarding work environment for employees, and seek a superior rate of return for investors and partners. | $86K | Series C | Jan 22, 2021 |  |

5 of 5 investments shown.

## Co-investors
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 2 deals together
- [Aopeng Investment](https://shizune.co/investors/profile/aopeng-investment) — VC Fund, 1 deal together
- [Apricot Capital](https://shizune.co/investors/profile/apricot-capital-ceb8) — VC Fund, 1 deal together
- [Changfa Development Investment](https://shizune.co/investors/profile/changfa-development-investment) — VC Fund, 1 deal together
- [Chip Aviation Capital](https://shizune.co/investors/profile/chip-aviation-capital) — VC Fund, 1 deal together
- [CITIC Securities](https://shizune.co/investors/profile/citic-securities) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Boquan Capital invest in?

Boquan Capital invests primarily in Biotechnology, Pharmaceutical and Medical startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Boquan Capital last invest?

The most recent investment recorded for Boquan Capital closed in Dec 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co